New combo therapy aims to shrink rectal tumors, spare patients from colostomy bags
NCT ID NCT06493240
Summary
This study tested a three-part treatment for rectal cancer that has not spread. Patients first received radiation with a chemotherapy pill, followed by an immunotherapy drug. The goal was to shrink the tumor completely before surgery, potentially allowing surgeons to preserve the anal sphincter and avoid a permanent colostomy bag.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOCALLY ADVANCED RECTAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, 100044, China
Conditions
Explore the condition pages connected to this study.